Gossamer Bio Announces Second Quarter 2019 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq reaches record high close, AI stocks rally
- Meta AI agent triggers heavy selloff in banks, insurers, and travel stocks
- Exclusive: SB Energy Nasdaq IPO moving forward as planned
- AI and earnings keep driving markets as focus shifts to Trump-Xi summit
- Meta bull case increasingly playing out, Mizuho says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Gossamer Bio Inc. (GOSS) Misses Q2 EPS by 18c
August 8, 2019 5:22 PM EDTGossamer Bio Inc. (NASDAQ: GOSS) reported Q2 EPS of ($0.74), $0.18 worse than the analyst estimate of ($0.56).
Over the last several months, we have made significant progress advancing our diversified development portfolio, with five clinical trials now active, said Sheila Gujrathi, M.D., Co-Founder and... More
